Windlas Biotech IPO fully subscribed: Grey market premium soars; should you invest as shares offered at 65x PE – The Financial Express
Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organizationWindlas Biotech’s Rs 401.53-crore IPO has been fully s…
